63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 363 / 薬物数 : 212 - (DrugBank : 43) / 標的遺伝子数 : 47 - 標的パスウェイ数 : 138

124 trials found

diseases per page:

Showing 1 to 10 of 124 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-004032-21-DK (EUCTR)	11/01/2022	16/04/2021	A Phase 3 study to evaluate the efficacy and safety of efgartigimod PH 20 Subcutaneous in adult pati ...	A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficac ...	Primary immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: LLT;Classification code 10083843;T ...	Product Name: efgartigimod PH20 SC INN or Proposed INN: efgartigimod alfa	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	Portugal;Serbia;United States;Taiwan;Greece;Spain;Thailand;Ireland;Israel;Chile;Russian Federation;C ...
2	NCT05029635 (ClinicalTrials.gov)	October 1, 2021	8/8/2021	Phase III Study on HMPL-523 for Treatment of ITP	A Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and ...	Immune Thrombocytopenia (ITP)	Drug: HMPL-523;Drug: Placebo	Hutchison Medipharma Limited	NULL	Not yet recruiting	18 Years	75 Years	All	177	Phase 3	NULL
3	EUCTR2019-000884-26-HR (EUCTR)	09/09/2021	24/11/2021	A study to evaluate the efficacy, safety, and tolerability of rozanolixizumab in adult study partici ...	A Phase 3 Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, ...	Primary Immune Thrombocytopenia MedDRA version: 20.0;Level: PT;Classification code 10043554;Term: Th ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	United States;Czechia;Taiwan;Greece;Spain;Ukraine;Turkey;Austria;Russian Federation;United Kingdom;I ...
4	EUCTR2020-004032-21-PT (EUCTR)	19/07/2021	11/03/2021	A Phase 3 study to evaluate the efficacy and safety of efgartigimod PH 20 Subcutaneous in adult pati ...	A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficac ...	Primary immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: LLT;Classification code 10083843;T ...	Product Name: efgartigimod PH20 SC INN or Proposed INN: efgartigimod alfa	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	Portugal;Serbia;United States;Taiwan;Greece;Spain;Thailand;Ireland;Israel;Chile;Russian Federation;C ...
5	EUCTR2020-004032-21-NO (EUCTR)	25/06/2021	18/03/2021	A Phase 3 study to evaluate the efficacy and safety of efgartigimod PH 20 Subcutaneous in adult pati ...	A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficac ...	Primary immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: LLT;Classification code 10083843;T ...	Product Name: efgartigimod PH20 SC INN or Proposed INN: efgartigimod alfa	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	United States;Serbia;Portugal;Taiwan;Greece;Thailand;Spain;Ireland;Russian Federation;Chile;Israel;C ...
6	EUCTR2019-003451-11-DK (EUCTR)	17/06/2021	19/04/2021	A study to assess the efficacy, safety, and tolerability of rozanolixizumab in adult study participa ...	A Phase 3 Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, ...	Primary Immune Thrombocytopenia MedDRA version: 20.0;Level: PT;Classification code 10043554;Term: Th ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	Serbia;United States;Czechia;Hong Kong;Taiwan;Spain;Ukraine;Turkey;Austria;Russian Federation;United ...
7	EUCTR2020-004032-21-DE (EUCTR)	15/06/2021	12/03/2021	A Phase 3 study to evaluate the efficacy and safety of efgartigimod PH 20 Subcutaneous in adult pati ...	A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficac ...	Primary immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: LLT;Classification code 10083843;T ...	Product Name: efgartigimod PH20 SC INN or Proposed INN: efgartigimod alfa	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	Portugal;Serbia;United States;Taiwan;Greece;Spain;Thailand;Ireland;Israel;Chile;Russian Federation;C ...
8	EUCTR2020-004032-21-IT (EUCTR)	04/06/2021	08/06/2021	A Phase 3 study to evaluate the efficacy and safety of efgartigimod PH20 Subcutaneous in adult patie ...	A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficac ...	Primary immune thrombocytopenia (ITP) MedDRA version: 22.1;Level: LLT;Classification code 10036735;T ...	Product Name: efgartigimod PH20 SC Product Code: [ARGX-113] INN or Proposed INN: efgartigimod alfa	ARGENX BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	Portugal;Serbia;United States;Taiwan;Greece;Spain;Thailand;Ireland;Israel;Chile;Russian Federation;C ...
9	JPRN-jRCT2071210025	25/05/2021	24/05/2021	A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficac ...	A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficac ...	Primary Immune Thrombocytopenia	Patients will receive ARGX-113 PH20 SC (1000 mg of Efgartigimod Alfa) or placeboPH20 SC, weekly from ...	Gandini Domenica	NULL	Recruiting	>= 20age old	Not applicable	Both	9	Phase 3	Denmark;France;Georgia;Germany;Greece;Ireland;Israel;Italy;Jordan;Republic of Korea;Latvia;Mexico;Ne ...
10	EUCTR2019-000884-26-GR (EUCTR)	25/05/2021	01/04/2021	A study to evaluate the efficacy, safety, and tolerability of rozanolixizumab in adult study partici ...	A Phase 3 Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, ...	Primary Immune Thrombocytopenia MedDRA version: 20.0;Level: PT;Classification code 10043554;Term: Th ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	United States;Czechia;Taiwan;Greece;Spain;Ukraine;Turkey;Austria;Russian Federation;United Kingdom;I ...

First Previous1 2 3 4 5…13Next Last